Stop us if you’ve heard this one before: there’s a drug out there that does a very specific thing, and has no generic alternative. For years, it sold for a predictable three-figure price point. Then one day, if gets acquired by a new company and in just a few months, the price increases by more than 4000%. It is, unfortunately, such a common tale of late that we all know the general outline by heart. And now it seems to be happening again. [More]
